Chongyuan Liu

Statistics

Publications

Citations

226

H-Index

Active since

1993

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Chongyuan Liu is an author at Memorial Sloan Kettering Cancer Center specializing in receptor tyrosine kinase signaling, bcr-abl dependence, and oncology.

Publications per year

1993–2003

Publications

Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.

David Wisniewski, C Lambek, Chongyuan Liu et al. · PubMed · 2002 · 161 citations

Medicine, Oncology, Pharmacology +15

Disialoganglioside G<sub>D2</sub> anti‐idiotypic monoclonal antibodies

Nai‐Kong V. Cheung, Adela Cañete, Irene Y. Cheung et al. · International Journal of Cancer · 1993 · 52 citations

Life Sciences, Immunology, Oncology +17

Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells.

A Strife, David Wisniewski, Chongyuan Liu et al. · PubMed · 2003 · 13 citations

Life Sciences, Cell Biology, Hematology +15

1–3 of 3